The competitive landscape of the Coronary Stents Market is fiercely contested, primarily dominated by a few multinational giants whose strategies are heavily focused on refining and diversifying their Drug-Eluting Stent (DES) portfolios. This market, which reached a valuation of $6.62 billion in 2024, is forecast to achieve a size of $9.2 billion by 2035, sustaining a CAGR of 3.04%. The battle...